InvestorsHub Logo
Followers 0
Posts 161
Boards Moderated 0
Alias Born 08/07/2014

Re: None

Tuesday, 03/10/2015 10:29:45 AM

Tuesday, March 10, 2015 10:29:45 AM

Post# of 1874
For Brad T.

As investors we all see how competitive the "Fight to stop cancer" industry is. These are others that are getting spotlighted in the investment world:

"Some other interesting small companies, basically one step ahead of Propanc Health Group Corp (PPCH), include: Stemline Therapeutics, Inc. (STML), Verastem, Inc. (VSTM), CTI BioPharma Corp. (CTIC). All three of these companies are oncology-focused Biotech firms, meaning they focus on Cancer treatments using a variety of advanced sciences."

If your company truly has a revolutionary drug ie "Reolysin" how can you improve getting better coverage of such a product? Are you interested in capturing the attention of big Pharma and/or partnering Reolysin which has repeatedly shown efficacy in several studies? We can assume that Reolysin could make it to market as clinical results favor such a product. However, when you publish news that sends the stock significantly, then it quickly retreats shows there is still doubt as to when Onolytics Biotech can actually begin sales.

I know you need FDA approval but is it possible you could fill in some blanks as to when this drug could reach the market. Forward looking statements are priceless and investors reward companies that have vision and punish those who lack clarity. Is Reolysin close to getting some final approval or is this simply in infancy for several years. The more investors understand your plans on execution the easier it will be to sustain gains rather than get shorted below 50 day MA every time news is released.

Thank you if can provide a little more positive news to follow up big news that deflates in a day.

A truly long investor
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCY News